This inventor holds 1 USPTO granted patent. Top assignee: Aicuris Gmbh + Co. Kg.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Kathe Goossen: Innovator in Antiviral Research
Introduction
Kathe Goossen is a prominent inventor based in Kaiserslautern, Germany. She has made significant contributions to the field of antiviral research, particularly through her innovative work on dihydroquinazolines. Her research focuses on developing compounds that can combat viral infections, showcasing her dedication to improving public health.
Latest Patents
Kathe Goossen holds a patent for a process for the preparation of dihydroquinazolines. This patent is particularly noteworthy as it details the synthesis of dihydroquinazolines of a specific formula. These compounds have been identified as useful antiviral agents, especially against cytomegaloviruses. Her work in this area highlights the potential for new treatments in the fight against viral diseases.
Career Highlights
Goossen is currently employed at Aicuris GmbH & Co. KG, where she continues her research and development efforts. Her role at the company allows her to collaborate with other experts in the field and contribute to innovative solutions for viral infections. With her extensive knowledge and experience, she has become a valuable asset to her team.
Collaborations
Some of her notable coworkers include Oliver Kuhn and Mathias Berwe. Their collaboration fosters a dynamic research environment, enabling the team to tackle complex challenges in antiviral research effectively.
Conclusion
Kathe Goossen's work exemplifies the impact of innovative research in the field of medicine. Her contributions to antiviral agents are paving the way for new treatments and improving health outcomes.